IRCT20230505058093N1招募中3 期
The efficacy of Lavandula stoechas product on motor symptoms of patients with Parkinson's disease treated with levodopa : A double-blind clinical trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- 干预性
入排标准
- 年龄范围
- 55 years 至 75 years(—)
- 性别
- All
入选标准
- Idiopathic Parkinson's disease
- Age range of 55 to 75 years
- The onset age of the disease is less than 5 years
- Stages one to three of Parkinson's disease
排除标准
- The lack of physical and mental ability to answer the questions
- Alcohol and drug use
- History of systemic physical diseases such as diabetes, heart and brain stroke, heart, respiratory and kidney failure and uncontrolled blood pressure
- Occurrence of debilitating disease during treatment
- Taking a new drug due to lack of response to levodopa treatment or intolerance to levodopa if the diagnosis is primary
- Taking sedative drugs or drugs that interfere with lavender, such as antipsychotic drugs, monoamine oxidase inhibitors, benzodiazepines, tricyclic antidepressants, anticonvulsants, and barbiturates.
研究者
标识符
- 注册编号
- IRCT20230505058093N1
日期
- 最近更新
- (2年前)
监管与共享
- 是否有结果
- 否
相似试验
已完成
3 期
同适应症 · 同分期A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/LevodopaParkinson's DiseaseNCT00134966Novartis493
已完成
3 期
同适应症 · 同分期A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease PatientsParkinson's DiseaseNCT01628926Otsuka Pharmaceutical Co., Ltd.420
终止
3 期
同适应症 · 同分期NET-PD LS-1 Creatine in Parkinson's DiseaseParkinson's DiseaseNCT00449865University of Rochester1,741
已完成
3 期
同适应症 · 同分期Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in ChinaParkinson's DiseaseNCT01556165H. Lundbeck A/S130
已完成
3 期
同适应症 · 同分期Clinical Trial of Apomorphine Subcutaneous Infusion in Patients With Advanced Parkinson's DiseaseParkinson's DiseaseNCT02006121Britannia Pharmaceuticals Ltd.107
